Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | aciclovir | 135398513 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | aciclovir | 135398513 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | guanabenz | 5702063 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | guanabenz | 5702063 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | guanabenz | 5702063 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | guanabenz | 5702063 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | guanabenz | 5702063 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | guanabenz | 5702063 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | guanabenz | 5702063 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | guanabenz | 5702063 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | guanabenz | 5702063 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | guanabenz | 5702063 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | guanabenz | 5702063 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | lisuride | 28864 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | lisuride | 28864 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | lisuride | 28864 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | daunorubicin | 30323 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | daunorubicin | 30323 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | daunorubicin | 30323 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | daunorubicin | 30323 | drug-path |